Vera Therapeutics Inc (VERA)
41.38
-0.56
(-1.34%)
USD |
NASDAQ |
May 17, 16:00
41.38
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Accounts Payable (Quarterly): 5.209M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.209M |
| December 31, 2023 | 11.12M |
| September 30, 2023 | 12.30M |
| June 30, 2023 | 13.28M |
| March 31, 2023 | 5.326M |
| December 31, 2022 | 11.99M |
| September 30, 2022 | 7.012M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.084M |
| March 31, 2022 | 7.328M |
| December 31, 2021 | 1.385M |
| September 30, 2021 | 0.964M |
| June 30, 2021 | 1.723M |
| March 31, 2021 | 1.44M |
| December 31, 2020 | 0.909M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.909M
Minimum
Dec 2020
13.28M
Maximum
Jun 2023
6.219M
Average
6.169M
Median
Accounts Payable (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 351.40M |
| Alpine Immune Sciences Inc | 4.17M |
| Fate Therapeutics Inc | 6.765M |
| Mersana Therapeutics Inc | 3.086M |
| Equillium Inc | 2.778M |